A biosimilar is a biologic product that is approved based on a demonstration that shows that it is highly similar to an approved biologic product, known as the reference product25-27

Biosimilars are developed to be highly similar to the reference product with no clinically meaningful differences in terms of quality, efficacy and safety25-27

Biosimilars can support a more sustainable healthcare system,28-31 expanding treatment options and enabling cost savings58 without compromising safety or efficacy25-27,32.

Potential Benefits of Biosimilars

Potential benefits of biosimilars for patients, payers and providers include:28-30

Potential Benefits of Biosimilars

Quote from NICE on Biosimilars


Adoption and use of biosimilars may help increase choice and potentially drive cost savings by stimulating competition between orginator biologics and their respective biosimilars as well as between biosimilars themselves33.

A competitive and sustainable marketplace that supports both the orginator biologics and biosimilars is necessary to obtain the benefits that those important medicines offer for patients, physicians, payers and healthcare systems34.

Watch our video to learn more:

PP-IFA-GBR-0279. December 2018